Abelacimab Withdrawn Phase 2 Trials for Atrial Fibrillation Basic Science
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Withdrawn | Basic Science | 2 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT03398434 | Efficacy and Safety of MAA868 in Patients With Atrial Fibrillation |